Cas no 1256346-30-1 (4-(Cyclohexanecarbonyl)phenylboronic acid)
4-(Cyclohexanecarbonyl)phenylboronic acid Chemical and Physical Properties
Names and Identifiers
-
- (4-(Cyclohexanecarbonyl)phenyl)boronic acid
- 4-(Cyclohexanecarbonyl)phenylboronic acid
- [4-(cyclohexanecarbonyl)phenyl]boronic acid
-
Computed Properties
- Exact Mass: 232.12700
Experimental Properties
- PSA: 57.53000
- LogP: 1.12940
4-(Cyclohexanecarbonyl)phenylboronic acid Customs Data
- HS CODE:2931900090
- Customs Data:
China Customs Code:
2931900090Overview:
2931900090. Other organic-Inorganic compound. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:AB(Customs clearance form for Inbound Goods,Customs clearance form for outbound goods). MFN tariff:6.5%. general tariff:30.0%
Summary:
2931900090. other organo-inorganic compounds. VAT:17.0%. Tax rebate rate:13.0%. Supervision conditions:AB(certificate of inspection for goods inward,certificate of inspection for goods outward). MFN tariff:6.5%. General tariff:30.0%
4-(Cyclohexanecarbonyl)phenylboronic acid Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| TRC | C991685-100mg |
4-(Cyclohexanecarbonyl)phenylboronic acid |
1256346-30-1 | 100mg |
$425.00 | 2023-05-18 | ||
| TRC | C991685-250mg |
4-(Cyclohexanecarbonyl)phenylboronic acid |
1256346-30-1 | 250mg |
$856.00 | 2023-05-18 | ||
| TRC | C991685-500mg |
4-(Cyclohexanecarbonyl)phenylboronic acid |
1256346-30-1 | 500mg |
$1321.00 | 2023-05-18 | ||
| TRC | C991685-1g |
4-(Cyclohexanecarbonyl)phenylboronic acid |
1256346-30-1 | 1g |
$1889.00 | 2023-05-18 | ||
| Chemenu | CM206622-1g |
(4-(Cyclohexanecarbonyl)phenyl)boronic acid |
1256346-30-1 | 95% | 1g |
$661 | 2023-01-10 | |
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1249042-1g |
4-(Cyclohexanecarbonyl)phenylboronic acid |
1256346-30-1 | 95+% | 1g |
¥5544.00 | 2024-08-09 | |
| Crysdot LLC | CD12168646-1g |
(4-(Cyclohexanecarbonyl)phenyl)boronic acid |
1256346-30-1 | 95+% | 1g |
$518 | 2024-07-23 |
4-(Cyclohexanecarbonyl)phenylboronic acid Related Literature
-
Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330
-
Bo Wei,Zhenyu Liu,Chen Xie,Shu Yang,Wentao Tang,Aiwei Gu,Wing-Tak Wong,Ka-Leung Wong J. Mater. Chem. C, 2015,3, 12322-12327
-
Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
-
Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283
-
Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
Additional information on 4-(Cyclohexanecarbonyl)phenylboronic acid
Introduction to 4-(Cyclohexanecarbonyl)phenylboronic acid (CAS No: 1256346-30-1)
4-(Cyclohexanecarbonyl)phenylboronic acid, identified by the Chemical Abstracts Service Number (CAS No) 1256346-30-1, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and materials science. This boronic acid derivative features a unique structural motif, combining a cyclohexanecarbonyl group with a phenyl ring linked by a boronic acid moiety. Such structural features make it a versatile intermediate in organic synthesis, particularly in cross-coupling reactions and as a ligand in catalytic systems.
The boronic acid functional group in this compound plays a pivotal role in its reactivity, enabling it to participate in various chemical transformations essential for drug development and material innovation. Boronic acids are well-known for their ability to form stable complexes with diols and other boron-containing species, making them invaluable in Suzuki-Miyaura cross-coupling reactions—a cornerstone of modern synthetic organic chemistry. The cyclohexanecarbonyl substituent introduces steric and electronic effects that can modulate the reactivity and selectivity of the boronic acid moiety, providing chemists with fine-tuned control over synthetic pathways.
In recent years, the pharmaceutical industry has seen a surge in the use of boronic acid derivatives due to their broad spectrum of applications. One notable area is in the development of targeted therapeutics, where boron-containing compounds have been explored for their potential in modulating enzyme activity and biological pathways. For instance, 4-(Cyclohexanecarbonyl)phenylboronic acid has been investigated as a precursor in the synthesis of novel inhibitors targeting diseases such as cancer and inflammatory disorders. Its structural flexibility allows for modifications that can enhance binding affinity and reduce off-target effects, which are critical factors in drug design.
The compound's utility extends beyond pharmaceuticals into materials science, particularly in the realm of organic electronics. Boronic acids are increasingly being employed in the synthesis of conjugated polymers and small-molecule semiconductors due to their ability to influence charge transport properties. The phenyl ring provides π-conjugation opportunities, while the cyclohexanecarbonyl group can serve as a steric anchor or electronic modifier. This combination makes 4-(Cyclohexanecarbonyl)phenylboronic acid a promising candidate for developing advanced optoelectronic materials, such as organic light-emitting diodes (OLEDs) and photovoltaic cells.
Recent advancements in green chemistry have also highlighted the importance of sustainable synthetic routes, and boronic acids fit well into this paradigm. The ability to perform efficient cross-coupling reactions under mild conditions reduces energy consumption and waste generation, aligning with global efforts toward environmental stewardship. Researchers have been exploring catalytic systems that employ 4-(Cyclohexanecarbonyl)phenylboronic acid to achieve high yields of desired products while minimizing hazardous byproducts. Such innovations underscore the compound's relevance in modern chemical manufacturing processes.
The compound's stability under various reaction conditions further enhances its appeal as an intermediate. Boronic acids are generally stable at ambient temperatures but can exhibit different reactivities depending on solvent polarity and pH. This characteristic allows chemists to tailor reaction conditions to optimize yield and purity. For example, polar aprotic solvents like dimethylformamide (DMF) or tetrahydrofuran (THF) are often preferred for Suzuki-Miyaura couplings involving 4-(Cyclohexanecarbonyl)phenylboronic acid, as they facilitate boronate complex formation and enhance reaction kinetics.
In conclusion, 4-(Cyclohexanecarbonyl)phenylboronic acid (CAS No: 1256346-30-1) represents a fascinating intersection of pharmaceutical chemistry and materials science. Its unique structural features make it an indispensable tool for synthetic chemists working on drug discovery and advanced materials. As research continues to uncover new applications for boronic acid derivatives, compounds like this one will undoubtedly play a central role in shaping the future of chemical innovation.
1256346-30-1 (4-(Cyclohexanecarbonyl)phenylboronic acid) Related Products
- 959861-28-0(4-(Cyclopropylcarbonyl)phenylboronic acid)
- 186498-24-8((4-Butyrylphenyl)boronic acid)
- 1106677-24-0(4-Hexanoylphenylboronic acid)
- 1256346-29-8(4-(3-Methylbutanoyl)phenylboronic acid)
- 1256346-28-7((4-(2-Cyclopropylacetyl)phenyl)boronic acid)
- 186498-27-1((4-Isobutyrylphenyl)boronic acid)
- 959861-30-4(4-(Cyclopentanecarbonyl)phenylboronic acid)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)